1. Metabolic Enzyme/Protease Anti-infection
  2. Squalene Monooxygenase Bacterial
  3. Tetramethylthiuram monosulfide

Tetramethylthiuram monosulfide  (Synonyms: TMTM; テトラメチルチウラムモノスルフィド)

製品番号: HY-W020246 純度: 99.71%
COA 取扱説明書 Technical Support

Tetramethylthiuram monosulfide (TMTM) is an orally active microsomal monooxygenases inhibitor. Tetramethylthiuram monosulfide is used as an accelerator and activator in the processing of natural rubber and butyl rubber. Tetramethylthiuram monosulfide reduces palmitic acid incorporation into microsomal phospholipids, disrupts microsomal membrane integrity, and impairs electron transport during oxygenation. Tetramethylthiuram monosulfide can be used for the research of fungal infection, bacterial infection and allergic contact dermatitis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Tetramethylthiuram monosulfide

Tetramethylthiuram monosulfide 構造式

CAS 番号 : 97-74-5

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 44 在庫あり
Solution
10 mM * 1 mL in DMSO USD 44 在庫あり
Solid
25 g $40 在庫あり
50 g $60 在庫あり
100 g $90 在庫あり
250 g $180 在庫あり
500 g $270 在庫あり
> 100 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Other Forms of Tetramethylthiuram monosulfide:

Top Publications Citing Use of Products
  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Tetramethylthiuram monosulfide (TMTM) is an orally active microsomal monooxygenases inhibitor. Tetramethylthiuram monosulfide is used as an accelerator and activator in the processing of natural rubber and butyl rubber. Tetramethylthiuram monosulfide reduces palmitic acid incorporation into microsomal phospholipids, disrupts microsomal membrane integrity, and impairs electron transport during oxygenation. Tetramethylthiuram monosulfide can be used for the research of fungal infection, bacterial infection and allergic contact dermatitis[1][2].

Cellular Effect
Cell Line Type Value Description References
HeLa IC50
> 5000 μM
Compound: 9
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
[PMID: 29216562]
体外実験

Tetramethylthiuram monosulfide (10-2000 μg/plate; 48 h) induces point mutations in Salmonella typhimurium LT2 strains TA 100 and TA 1535 (especially with metabolic activation) and has a weak mutagenic effect in strain TA 1537, but does not induce mutations in strains TA 98 and TA 1538; higher doses exhibit bacteriotoxicity[1].
Tetramethylthiuram monosulfide (0.2 ppm; 96 h) is cytotoxic to normal Hartley guinea pig lymph node cells at concentrations of 0.2 ppm and above when incubated with PHA stimulation[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Tetramethylthiuram monosulfide (26-867 mg/kg; p.o.; single dose or 5 consecutive days per week for 4 weeks) inhibits rat hepatic microsomal monooxygenases at oral doses as low as 26 mg/kg, induces hematological, weight, and histopathological changes with 4-week 26 mg/kg/day dosing, and shows enhanced effects at 867 mg/kg[1].
Tetramethylthiuram monosulfide (500-2500 mg/kg; p.o.; single dose) has an acute oral LD50 of 818 mg/kg in adult female NMRI mice, with dose-dependent mortality and characteristic intoxication symptoms[1].
Tetramethylthiuram monosulfide (5%; intradermal injection; epicutaneous via occlusive patch for sensitization; 2.0%; epicutaneous via Finn chamber, 24 hours for challenge) induces contact hypersensitivity in female Hartley guinea pigs, with 62.5% of sensitized animals displaying positive patch test reactions after epicutaneous challenge[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Wistar (adult female, SPF, 180-200 g)[1]
Dosage: 26 mg/kg; 867 mg/kg
Administration: p.o.; single dose or 5 consecutive days per week for 4 weeks
Result: Prolonged hexobarbital sleeping time significantly, and decreased incorporation of [1-14C] palmitic acid into microsomal phospholipids of isolated perfused livers (26 mg/kg single dose).
Left zoxazolamine paralysis time unchanged (26 mg/kg single dose).
Prolonged both hexobarbital sleeping time and zoxazolamine paralysis time significantly, and produced a greater decrease in [1-14C] palmitic acid incorporation into all microsomal phospholipids compared to the 26 mg/kg dose (867 mg/kg single dose).
Decreased erythrocyte count from 5.96×106 to 4.32×106 significantly (26 mg/kg/day, 4-week treatment).
Decreased hemoglobin content from 14.19 g% to 13.20 g% significantly (26 mg/kg/day, 4-week treatment).
Caused initial body weight loss with moderate ongoing reduction, decreased food intake, increased water consumption, increased relative liver weight, and mild histopathological changes including generalized hepatocellular swelling and renal tubular epithelial swelling (26 mg/kg/day, 4-week treatment).
Left blood clinicochemical parameters (total protein, BUN, creatinine, alkaline phosphatase, GPT) and hepatic microsomal parameters (protein, cytochrome P-450, glucose-6-phosphatase, malondialdehyde, O-demethylase activity) unchanged (26 mg/kg/day, 4-week treatment).
Animal Model: NMRI (adult female, 20-25 g, acute toxicity)[1]
Dosage: 500 mg/kg; 750 mg/kg; 1000 mg/kg; 1250 mg/kg; 1500 mg/kg; 2000 mg/kg; 2250 mg/kg; 2500 mg/kg
Administration: p.o.; single dose
Result: Resulted in an acute oral LD50 of 818 mg/kg.
Caused intoxication symptoms including tachypnea, tachycardia, miosis, rare convulsions, and extremity paralysis.
Showed dose-dependent mortality onset, varying from 1 hour (2500 mg/kg) to 24 hours across doses.
Animal Model: Hartley (female, 300-400 g)[3]
Dosage: 5% (sensitization); 2.0% (challenge)
Administration: intradermal injection; epicutaneous via occlusive patch (sensitization); epicutaneous via Finn chamber, 24 hours (challenge)
Result: Induced positive patch test reactions in 62.5% of sensitized guinea pigs.
Induced doubtful reactions in 25% of sensitized guinea pigs.
Induced negative reactions in 12.5% of sensitized guinea pigs.
Resulted in negative reactions in all control guinea pigs.
分子量

208.37

分子式

C6H12N2S3

CAS 番号
Appearance

Solid

Color

Light yellow to yellow

SMILES

S=C(SC(N(C)C)=S)N(C)C

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
溶剤 & 溶解度
体外: 

DMSO : 200 mg/mL (959.83 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.7992 mL 23.9958 mL 47.9916 mL
5 mM 0.9598 mL 4.7992 mL 9.5983 mL
10 mM 0.4799 mL 2.3996 mL 4.7992 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.08 mg/mL (9.98 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (9.98 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション

純度: 99.71%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.7992 mL 23.9958 mL 47.9916 mL 119.9789 mL
5 mM 0.9598 mL 4.7992 mL 9.5983 mL 23.9958 mL
10 mM 0.4799 mL 2.3996 mL 4.7992 mL 11.9979 mL
15 mM 0.3199 mL 1.5997 mL 3.1994 mL 7.9986 mL
20 mM 0.2400 mL 1.1998 mL 2.3996 mL 5.9989 mL
25 mM 0.1920 mL 0.9598 mL 1.9197 mL 4.7992 mL
30 mM 0.1600 mL 0.7999 mL 1.5997 mL 3.9993 mL
40 mM 0.1200 mL 0.5999 mL 1.1998 mL 2.9995 mL
50 mM 0.0960 mL 0.4799 mL 0.9598 mL 2.3996 mL
60 mM 0.0800 mL 0.3999 mL 0.7999 mL 1.9996 mL
80 mM 0.0600 mL 0.2999 mL 0.5999 mL 1.4997 mL
100 mM 0.0480 mL 0.2400 mL 0.4799 mL 1.1998 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Tetramethylthiuram monosulfide
製品番号:
HY-W020246
数量:
MCE 日本正規代理店: